CHEMOTHERAPY AND GRANULOCYTE-COLONY-STIMULATING FACTOR IN OVARIAN-CANCER

被引：0
|
作者：
OCHIAI, K
TERASHIMA, Y
机构：
来源：
SEMINARS IN ONCOLOGY | 1994年 / 21卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：23 / 28
页数：6
相关论文
共 50 条
  • [31] PROTEIN TAILORING OF HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR
    ISHIKAWA, M
    OKADA, Y
    ISHIKAWA, R
    TSUMURA, H
    MATSUKI, S
    ASANO, K
    BIOTECHNOLOGY LETTERS, 1993, 15 (07) : 673 - 678
  • [32] Effects of granulocyte-colony-stimulating factor on potential normal granulocyte donors
    McCullough, J
    Clay, M
    Herr, G
    Smith, J
    Stroncek, D
    TRANSFUSION, 1999, 39 (10) : 1136 - 1140
  • [33] The Role of Prophylactic Application of Granulocyte Colony Stimulating Factor in Adjuvant Chemotherapy for Epithelial Ovarian Cancer
    Zhao, Yi
    Luan, Xiaofei
    Zheng, Chanfan
    Wang, Yuya
    CLINICAL LABORATORY, 2022, 68 (01) : 179 - 186
  • [34] Granulocyte-macrophage colony stimulating factor prior to chemotherapy for advanced epithelial ovarian cancer
    Guner, H
    Oktem, M
    Dilek, TUK
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2003, 83 (03) : 317 - 318
  • [35] Preoperative FLAC/Granulocyte-Colony-Stimulating Factor Chemotherapy for Stage II Breast Cancer: A Prospective Randomized Trial
    David N. Danforth
    Kenneth Cowan
    Rosemary Altemus
    Maria Merino
    Catherine Chow
    Arlene Berman
    Usha Chaudhry
    Craig Shriver
    Seth M. Steinberg
    JoAnne Zujewski
    Annals of Surgical Oncology, 2003, 10
  • [36] Benefits of granulocyte-colony-stimulating factor after stem cell transfusion in intensive sequential chemotherapy for breast cancer
    Viens, P
    Genre, D
    Protière, C
    Gravis, G
    Bertucci, F
    Cowen, D
    Camerlo, J
    Chabannon, C
    Novakovitch, G
    Conte, M
    Finaud, M
    Moatti, JP
    Maraninchi, D
    EUROPEAN CYTOKINE NETWORK, 1998, 9 (01) : 93 - 98
  • [37] Preoperative FLAC/granulocyte-colony-stimulating factor chemotherapy for stage II breast cancer: A prospective randomized trial
    Danforth, DN
    Cowan, K
    Altemus, R
    Merino, M
    Chow, C
    Berman, A
    Chaudhry, U
    Shriver, C
    Steinberg, SM
    Zujewski, J
    ANNALS OF SURGICAL ONCOLOGY, 2003, 10 (06) : 635 - 644
  • [38] Optimal use of granulocyte-colony-stimulating factor in patients with cancer who are at risk for chemotherapy-induced neutropenia
    Cappozzo, C
    ONCOLOGY NURSING FORUM, 2004, 31 (03) : 569 - 574
  • [39] EVIDENCE FOR THE GLYCOSYLATION OF THE GRANULOCYTE-COLONY-STIMULATING FACTOR-RECEPTOR
    LI, JM
    SARTORELLI, AC
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1994, 205 (01) : 238 - 244
  • [40] REGULATION OF GRANULOCYTE-COLONY-STIMULATING FACTOR AND GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR EXPRESSION BY ONCOSTATIN-M
    BROWN, TJ
    LIU, JW
    BRASHEMSTEIN, C
    SHOYAB, M
    BLOOD, 1993, 82 (01) : 33 - 37
12345